Epitomee Medical Ltd
EPTMF
$0.9892
-$0.0327-3.20%
OTC PK
| 06/30/2024 | 03/31/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | 0.00% | 33.75% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 0.00% | 6.18% | |||
| Operating Income | 0.00% | -186.74% | |||
| Income Before Tax | 0.00% | -702.09% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 0.00% | -702.09% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 0.00% | -702.09% | |||
| EBIT | 0.00% | -186.74% | |||
| EBITDA | 0.00% | -181.55% | |||
| EPS Basic | 0.00% | -698.23% | |||
| Normalized Basic EPS | 0.00% | -174.71% | |||
| EPS Diluted | 0.00% | -698.23% | |||
| Normalized Diluted EPS | 0.00% | -174.71% | |||
| Average Basic Shares Outstanding | 0.00% | 0.09% | |||
| Average Diluted Shares Outstanding | 0.00% | 0.09% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||